Sodium Hydroxide → HCID 178468418、化合物
反応式
FC(F)(F)C(O)=O.[CH:8]1([C:14]2([C:20]([O:22][CH2:23][CH3:24])=[O:21])[CH2:19][CH2:18][NH:17][CH2:16][CH2:15]2)[CH2:13][CH2:12][CH2:11][CH2:10][CH2:9]1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.[CH2:47]([N:49]([CH2:66][CH2:67][C:68]1[N:69]=[CH:70][NH:71][CH:72]=1)[C:50](=[O:65])[NH:51][CH:52]([CH2:56][C:57]1[CH:62]=[CH:61][C:60]([O:63][CH3:64])=[CH:59][CH:58]=1)[C:53](O)=[O:54])[CH3:48].C(N(C(C)C)CC)(C)C.[OH-].[Na+]>ClCCl.CN(C)C=O>[CH:8]1([C:14]2([C:20]([O:22][CH2:23][CH3:24])=[O:21])[CH2:15][CH2:16][N:17]([C:53](=[O:54])[CH:52]([NH:51][C:50]([N:49]([CH2:47][CH3:48])[CH2:66][CH2:67][C:68]3[N:69]=[CH:70][NH:71][CH:72]=3)=[O:65])[CH2:56][C:57]3[CH:58]=[CH:59][C:60]([O:63][CH3:64])=[CH:61][CH:62]=3)[CH2:18][CH2:19]2)[CH2:9][CH2:10][CH2:11][CH2:12][CH2:13]1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
66 mg (0.19 mmol) of ethyl 4-cyclohexylpiperidine-4-carboxylate trifluoroacetate are diluted in 3 mL of dichloromethane and 3 mL of dimethylformamide, and 67 mg (0.21 mmol) of TBTU and 75 mg (0.21 mmol) of 2-{3-ethyl-3-[2-(1H-imidazol-4-yl)ethyl]ureido}-3-(4-methoxyphenyl)propionic acid and 0.06 mL (0.38 mmol) of diisopropylethylamine are added. After 2 hours of stirring at room temperature, aqueous 1N NaOH solution is added and the organic products are extracted with dichloromethane. The organic phase is dried and then evaporated. The crude product obtained is chromatographed on silica gel (eluent: 95/5 dichloromethane/methanol). 34 mg of ethyl 4-cyclohexyl-1-[2-{3-ethyl-3-[2-(1H-imidazol-4-yl)ethyl]ureido}-3-(4-methoxyphenyl)propionyl]piperidine-4-carboxylate in the form of a yellow oil are obtained in a yield of 30%.
後処理
- extractionthe organic products are extracted with dichloromethane
- customThe organic phase is dried
- customevaporated
- customThe crude product obtained
- customis chromatographed on silica gel (eluent: 95/5 dichloromethane/methanol)
出典と根拠
- ORDレコード
- ord-711ed4cda52643c590fffc6db535f3dc
- 出典データセット
- uspto-grants-2014_11
- 特許番号
- US08877968B2
反応ノート
読み込み中…